Valuation: genOway

Market Cap 23.05M 26.22M 21.46M 19.71M 37M 2.51B 37.49M 255M 99.61M 1.24B 98.43M 96.31M 4.29B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.77M 33.86M 27.71M 25.45M 47.79M 3.25B 48.42M 329M 129M 1.6B 127M 124M 5.54B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.60%
1 week-1.60%
Current month+3.80%
1 month+4.24%
6 months-3.53%
Current year-9.23%
1 week 2.46
Extreme 2.46
2.51
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/1/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-1.60%-18.27%-35.60% 26.22M
+0.14%-0.28%-0.50%+11.45% 47.74B
-1.96%+0.81%+395.91%+618.69% 39.98B
+0.54%+2.80%+11.24%+45.52% 36.23B
+12.58%+19.49%+21.82%+6.53% 35.59B
-0.73%+2.78%+4.65%+41.16% 27.91B
-1.45%-2.02% - - 16.71B
-1.41%+10.12%+29.23%+129.77% 16.45B
+2.39%-1.64%+4.74%+9.95% 13.21B
+7.67%+8.71%-4.49%-28.16% 12.93B
Average +1.59%+2.58%+49.37%+88.81% 24.68B
Weighted average by Cap. +1.87%+2.95%+76.52%+131.33%

Financials

2024 2025
Net sales 27.53M 31.32M 25.63M 23.54M 44.2M 3B 44.78M 305M 119M 1.48B 118M 115M 5.13B 28.6M 32.53M 26.62M 24.45M 45.91M 3.12B 46.52M 316M 124M 1.54B 122M 119M 5.32B
Net income 1.83M 2.08M 1.7M 1.57M 2.94M 200M 2.98M 20.26M 7.91M 98.61M 7.82M 7.65M 341M 928K 1.06M 864K 793K 1.49M 101M 1.51M 10.27M 4.01M 49.97M 3.96M 3.88M 173M
Net Debt 623K 709K 580K 533K 1M 67.96M 1.01M 6.89M 2.69M 33.56M 2.66M 2.6M 116M 6.72M 7.64M 6.25M 5.74M 10.78M 733M 10.93M 74.33M 29.03M 362M 28.69M 28.07M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
28/07/26 EUR 2.460 -1.60% 736
27/07/26 EUR 2.500 +0.81% 3,349
24/07/26 EUR 2.480 +0.40% 13,571
23/07/26 EUR 2.470 -1.20% 17,468
22/07/26 EUR 2.500 0.00% 1,510
  1. Stock Market
  2. Stocks
  3. ALGEN Stock